Generation of stable monocyte-derived dendritic cells in the presence of high concentrations of homologous or autologous serum: Influence of extra- cellular pH

Human Immunology

Volumn 59, Issue 10, 1998, Pages 625-634

  Eljaafari, Assia ^a   Duperrier, Karine ^a   Mazet, Séverine ^a   Bardin, Christine ^a   Bernaud, Janine ^a   Durand, Brigitte ^a   Gebuhrer, Lucette ^a   Bétuel, Hervé ^a   Rigal, Dominique ^a  

^a Etablissement de Transfus Sanguine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; CELL PH; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONOCYTE; PRIORITY JOURNAL;

ANTIGENS, CD; BLOOD; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; CULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; HLA-DR ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; MONOCYTES;

EID: 0031752570     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00066-4     Document Type: Article

References (36)

1. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 9:1991;271.
2. Steinman R.M., Pack M., Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev. 156:1997;25.
3. +T cells in vitro characteristics and antigen-presenting cell requirements . J Exp Med. 176:1992;1431.
4. Inaba K., Schuler G., Witmer M.D., Valinsky J., Atassi B., Steinman R.M. Immunologic properties of purified epidermal Langerhans cells Distinct requirements for stimulation of unprimed and sensitized T lymphocytes . J Exp Med. 164:1986;605.
5. + T cells and process soluble antigen. J Immunol. 155:1995;5427.
6. Steinman R.M., Nussenzweig M.C. Dendritic cells features and functions . Immunol Rev. 53:1980;127.
7. Thomas R., Davis L.S., Lipsky P.E. Isolation and characterization of human peripheral blood dendritic cells. J Immunol. 150:1993;821.
8. + peripheral blood monocytes. J Immunol. 157:1996;3850.
9. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingstone A.M., Fathman C.G., Inaba K., Steinman R.M. Presentation of exogenous protein antigens by dendritic cells to T cell clones intact protein is presented best by immature epidermal Langerhans cells . J Exp Med. 169:1989;1169.
10. Austyn J.M. Antigen uptake and presentation by dendritic leukocytes. Semin Immunol. 4:1996;227.
11. Steinman R.M., Hoffman L., Pope M. Maturation and migration of cutaneous dendritic cells. J Invest Dermatol. 105:1995;2S.
12. Young J.W., Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex- restricted antitumor immunity. J Exp Med. 183:1996;7.
13. Paglia P., Chiodoni C., Rodolfo M., Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med. 183:1996;317.
14. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:1996;52.
15. Mayordomo J.I., Zorina T., Storkus W.J., Zitvogel L., Celluzzi C., Falo L.D., Melief C.J., Ildstad S.T., Kast W.M., Deleo A.B., Lotze M.T. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1995;1297.
16. Zitvogel L., Mayordomo J.I., Tjandrawan T., Deleo A.B., Clarke M.R., Lotze M.T., Storkus W.J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines . J Exp Med. 183:1996;87.
17. Inaba K., Inaba M., Deguchi M., Hagi K., Yasumizu R., Ikehara S., Muramatsu S., Steinman R.M. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA. 90:1993;3038.
18. + progenitors in human bone marrow. J Immunol. 149:1992;2681.
19. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF9 cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258.
20. +blood progenitors for anticancer therapy. Exp Hematol. 23:1995;1463.
21. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor 9. J Exp Med. 179:1994;1109.
22. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med. 180:1994;83.
23. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicability . J Immunol Methods. 196:1996;137.
24. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods. 196:1996;121.
25. Möst J., Spötl L., Mayr G., Gasser A., Sarti A., Dierich M.P. Formation of multinucleated giant cells in vitro is dependent on the stage of monocyte to macrophage maturation. Blood. 89:1997;662.
26. Dougherty GJ, Mc Bride WH: Monocyte differentiation in vitro. In Human monocytes. M. Zembala, and GL Asherson, editors. Academic Press, London 49, 1989.
27. Fitzgerald R.C., Omary M.B., Triadofilopoulos G. Acid modulation of HT29 cell growth and differentiation. J Cell Science. 110:1997;663.
28. Kerckaert G.A., Leboeuf R.A., Isfort R.J. PH effects on the lifespan and transformationfrequency of SHE cells. Carcinogenesis. 17:1996;1819.
29. McAdams T.A., Miller W.M., Papoutsakis E.T. Hematopoietic cell culture therapies. Trends in Biotechnology. 14:1996;341.
30. Zhou L.J., Tedder J.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 154:1995;3821.
31. Mc Lellan A.D., Starling G.C., Williams L.A., Hock B.D., Hart D.N.J. Activation of human peripheral blood dendritic cells induces the co-stimulatory molecule. Eur J Immunol. 25:1995;2064.
32. + human blood dendritic cells for active tumor immunotherapy. Exp Hematol. 25:1997;232.
33. Larsen C.P., Steinman R.M., Witmer-Pack M., Haukins D.F., Morris P.J., Austyn J.M. Migration and maturation of Langerhans cells in skin transplants and extracts. J Exp Med. 172:1990;1483.
34. Wiegmann K., Schütze S., Machleidt T., Witte D., Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1994;1005.
35. Chaux P., Favre N., Martin M., Martin F. Tumor infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7-2 expression in rats. Int J Cancer. 72:1997;619.
36. Kraus M., Wolf B. Implications of acidic tumor microenvironment for neoplastic growth and cancer treatment A computer analysis . Tumor Biol. 17:1996;133.